Logo image of SG

SWEETGREEN INC - CLASS A (SG) Stock Fundamental Analysis

USA - NYSE:SG - US87043Q1085 - Common Stock

8.02 USD
-0.13 (-1.6%)
Last: 9/29/2025, 8:06:48 PM
8.02 USD
0 (0%)
Pre-Market: 9/30/2025, 4:08:41 AM
Fundamental Rating

3

SG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of SG is average, but there are quite some concerns on its profitability. SG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SG had negative earnings in the past year.
SG had a positive operating cash flow in the past year.
In the past 5 years SG always reported negative net income.
In multiple years SG reported negative operating cash flow during the last 5 years.
SG Yearly Net Income VS EBIT VS OCF VS FCFSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.79%, SG is doing worse than 85.19% of the companies in the same industry.
SG's Return On Equity of -23.16% is in line compared to the rest of the industry. SG outperforms 42.22% of its industry peers.
Industry RankSector Rank
ROA -11.79%
ROE -23.16%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
SG Yearly ROA, ROE, ROICSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 27.67%, SG is doing worse than 78.52% of the companies in the same industry.
In the last couple of years the Gross Margin of SG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
SG Yearly Profit, Operating, Gross MarginsSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

6

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SG has been increased compared to 1 year ago.
Compared to 5 years ago, SG has more shares outstanding
There is no outstanding debt for SG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SG Yearly Shares OutstandingSG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SG Yearly Total Debt VS Total AssetsSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

SG has an Altman-Z score of 0.40. This is a bad value and indicates that SG is not financially healthy and even has some risk of bankruptcy.
SG has a Altman-Z score of 0.40. This is in the lower half of the industry: SG underperforms 78.52% of its industry peers.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACC8.92%
SG Yearly LT Debt VS Equity VS FCFSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SG has a Current Ratio of 1.82. This is a normal value and indicates that SG is financially healthy and should not expect problems in meeting its short term obligations.
SG has a Current ratio of 1.82. This is amongst the best in the industry. SG outperforms 81.48% of its industry peers.
A Quick Ratio of 1.80 indicates that SG should not have too much problems paying its short term obligations.
SG has a better Quick ratio (1.80) than 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.8
SG Yearly Current Assets VS Current LiabilitesSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for SG have decreased by -5.00% in the last year.
SG shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
The Revenue has been growing by 19.81% on average over the past years. This is quite good.
EPS 1Y (TTM)-5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%0.51%

3.2 Future

The Earnings Per Share is expected to grow by 12.04% on average over the next years. This is quite good.
Based on estimates for the next years, SG will show a quite strong growth in Revenue. The Revenue will grow by 12.48% on average per year.
EPS Next Y-0.83%
EPS Next 2Y8.24%
EPS Next 3Y8.71%
EPS Next 5Y12.04%
Revenue Next Year4.72%
Revenue Next 2Y11.39%
Revenue Next 3Y13.1%
Revenue Next 5Y12.48%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SG Yearly Revenue VS EstimatesSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
SG Yearly EPS VS EstimatesSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SG Price Earnings VS Forward Price EarningsSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SG Per share dataSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.24%
EPS Next 3Y8.71%

More info and screens

0

5. Dividend

5.1 Amount

SG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SWEETGREEN INC - CLASS A

NYSE:SG (9/29/2025, 8:06:48 PM)

Premarket: 8.02 0 (0%)

8.02

-0.13 (-1.6%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-07 2025-11-07/amc
Inst Owners104.78%
Inst Owner Change-3.91%
Ins Owners0.96%
Ins Owner Change0.18%
Market Cap948.04M
Analysts79.09
Price Target14.65 (82.67%)
Short Float %18.66%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.66%
Min EPS beat(2)-60.58%
Max EPS beat(2)9.26%
EPS beat(4)1
Avg EPS beat(4)-24.67%
Min EPS beat(4)-60.58%
Max EPS beat(4)9.26%
EPS beat(8)2
Avg EPS beat(8)-20.78%
EPS beat(12)4
Avg EPS beat(12)-14.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.21%
Min Revenue beat(2)-6.23%
Max Revenue beat(2)-2.2%
Revenue beat(4)0
Avg Revenue beat(4)-3.96%
Min Revenue beat(4)-6.23%
Max Revenue beat(4)-2.2%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)1
Avg Revenue beat(12)-3.79%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.06%
PT rev (3m)-38.04%
EPS NQ rev (1m)-2.09%
EPS NQ rev (3m)-24.44%
EPS NY rev (1m)-3.66%
EPS NY rev (3m)-22.31%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)-7.23%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-5.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF 52.14
P/B 2.24
P/tB 2.6
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.15
OCFY1.92%
SpS5.81
BVpS3.58
TBVpS3.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.79%
ROE -23.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.67%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.14%
Cap/Sales 14.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.8
Altman-Z 0.4
F-Score4
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)172.66%
Cap/Depr(5y)198.17%
Cap/Sales(3y)17.26%
Cap/Sales(5y)20.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y-0.83%
EPS Next 2Y8.24%
EPS Next 3Y8.71%
EPS Next 5Y12.04%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%0.51%
Revenue Next Year4.72%
Revenue Next 2Y11.39%
Revenue Next 3Y13.1%
Revenue Next 5Y12.48%
EBIT growth 1Y-1.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.85%
EBIT Next 3Y40.09%
EBIT Next 5Y27.84%
FCF growth 1Y37.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y193.97%
OCF growth 3YN/A
OCF growth 5YN/A